MITOMYCIN-C AND VINBLASTINE IN ADVANCED REFRACTORY BREAST-CANCER

被引：13

作者：

BRAMBILLA, C ^{[1
]}

ZAMBETTI, M ^{[1
]}

FERRARI, L ^{[1
]}

BONADONNA, G ^{[1
]}

机构：

[1] IST NAZL TUMORI,DIV MED ONCOL,VAI G VENEZIAN 1,I-20133 MILAN,ITALY

来源：

TUMORI | 1989年 / 75卷 / 02期

关键词：

D O I：

10.1177/030089168907500212

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：141 / 144

页数：4

共 20 条

[1]

BISHOP JF, 1987, CANCER TREAT REP, V71, P191

[2] CHEMOTHERAPY OF BREAST-CANCER - CURRENT VIEWS AND RESULTS [J].

BONADONNA, G ;

VALAGUSSA, P .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (03) :279-297

[3] MITOMYCIN-C IS AN INACTIVE DRUG IN THE 3RD-LINE TREATMENT OF HORMONE AND CHEMOTHERAPY REFRACTORY BREAST-CANCER [J].

DEES, A ;

VERWEIJ, J ;

VANPUTTEN, WLJ ;

STOTER, G .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09) :1343-1347

[4]

DENEFRIO JM, 1978, CANCER TREAT REP, V62, P2113

[5] MITOMYCIN - 10 YEARS AFTER APPROVAL FOR MARKETING [J].

DOLL, DC ;

WEISS, RB ;

ISSELL, BF .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (02) :276-286

[6]

FRASCHINI G, 1985, CANCER-AM CANCER SOC, V56, P225, DOI 10.1002/1097-0142(19850715)56:2<225::AID-CNCR2820560203>3.0.CO

[7]

2-Y

[8] TREATMENT OF ADVANCED BREAST-CANCER WITH MITOMYCIN-C COMBINED WITH VINBLASTINE OR VINDESINE [J].

GAREWAL, HS ;

BROOKS, RJ ;

JONES, SE ;

MILLER, TP .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) :772-775

[9]

HENDERSON IC, 1987, SEMIN ONCOL, V14, P34

[10]

HORTOBAGYI GN, 1985, SEMIN ONCOL, V12, P65

← 1 2 →